The Emerging Role of CGM for Patients with Type 2 Diabetes: Rationale, Evidence, and Practice Pearls for Integration
Continuous glucose monitoring (CGM) has emerged as a clinically useful tool for the management of patients with type 2 diabetes, as it provides real-time data to better guide glycemic variability, improve glycemic control, as well as reduce the risk of hypoglycemia and hospitalizations.
Category
  • CMHC
Format
  • Video
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Clinical Brief: Prevention and Treatment of Influenza in High-Risk Patients with Cardiometabolic Comorbidities
This enduring clinical brief was developed from a primetime symposium at the 2021 CMHC Annual Congress. Moderated by Dr. Gregory Poland, the symposium reviewed the latest literature on the epidemiology, prevention, diagnosis, and treatment for influenza.
Category
  • CMHC
Format
  • Monograph
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Clinical Brief: Challenges and Advances in Diabetic Kidney Disease
This enduring clinical brief was developed from a primetime symposium at the 2021 CMHC Annual Congress. Moderated by Dr. Bakris, the symposium highlighted the importance of and the challenges in managing renal disease in patients with diabetes.
Category
  • CMHC
Format
  • Monograph
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
An Overview of GLP-1 RAs for CV Risk Reduction in T2DM Patients
GLP-1 RAs have carved an important role in the management of patients with type 2 diabetes (T2D), not only in glycemic control, but also in reducing cardiovascular and renal risk.
Category
  • CMHC
Format
  • Self-study / Enduring
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation